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AbSTRAcT
Although autoimmune hypothyroidism has generally been considered to be a disease that mainly 
develops because of genetic aberrations and for which adjustment of environment would bring 
about but slight risk modification, this understanding is increasingly appearing to be incorrect. 
We describe how iodine intake, smoking cessation and alcohol intake are all strong modifiers 
of risk that, combined, may influence risk by a factor of up to 30.
Unfortunately, promotion of an environment leading to substantial lowering of the risk of 
autoimmune hypothyroidism (i.e. improvement of dietary iodine deficiency, decrease or cessa-
tion of smoking, and moderate alcohol intake) is not incorporated within current public health 
promoting programs. Nevertheless, it is increasingly becoming evident that knowledge of the 
importance of these factors for disease development is likely to assist in the planning of health 
promotion programs, while it will surely also be of value in the care of individual patients.
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While prevention of disease is, according to the 
available evidence, the most cost-effective way of 
reducing the burden of disease in a population,1 the 
concept of prevention of autoimmune thyroid disease 
is nevertheless frequently met with scepticism. This 
is because thyroid autoimmunity is considered to 
be caused predominantly by genetic aberrations.2,3 
People are believed to be more or less ‘pre-destined’ 
to develop disease if they harbour ‘the wrong genes’, 
with little possibility of prevention.
This understanding does not seem to be correct, 
as discussed by Rothman and colleagues.4 Practically 
all diseases have multi-factorial etiology and cases 
* According to Greek mythology, the sea-monsters Scylla and 
Charybdis were on either side of a strait so narrow that sailors 
attempting to avoid one monster would come dangerously 
close to the other.
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can be attributed to both genes and environment. 
The fractions of disease attributable to genes and 
environment overlap and would normally add up 
to more than 100%. A specific case of disease may 
be 100% preventable by a change of environment, 
even if the disease is 100% dependent on a genetic 
abnormality. An example given by Rothman et al4 
is phenylketonuria. In this disease, mental retarda-
tion is caused by a genetic disorder, but it is entirely 
preventable by diet.
Recent studies have identified a number of modi-
fiable environmental risk factors having a strong 
influence on the occurrence of autoimmune hypo-
thyroidism, and considerable reduction of risk is in 
principle possible via a program of primary prevention 
addressing the population as a whole.
Unfortunately, the present combination of effec-
tive measures includes: 1. that the population be kept 
iodine deficient, 2. that smokers be convinced not to 
quit tobacco, and 3. that people have a relatively high 
intake of alcohol. However, changes of these condi-
tions in environment would unacceptably increase 
the risk of other diseases, and a balance has to be 
found. In this article, the association between these 
risk factors and the development of overt autoim-
mune hypothyroidism will be discussed. Additional 
environmental factors often mentioned in relation to 
risk of autoimmune thyroid disease, such as stress, 
minerals and vitamins in diet, various medications 
and chemicals, fetal life, pregnancy, and infections, 
are not discussed.
ioDine Deficiency anD tHe Risk  
of Disease
The iodine intake of a given population has a 
profound effect on the balance in occurrence of the 
various thyroid disorders.5 The most serious pat-
tern of disease is observed when iodine deficiency 
is severe inducing insufficient thyroid hormone pro-
duction, as can be seen when the median urinary 
iodine concentration in a population is below 20 
µg/L.6 Thyroid hormones are important regulators 
of brain development, and irreversible brain damage 
with some degree of mental retardation may affect a 
considerable proportion of the population. In addi-
tion, many members of society will suffer from goitre 
and thyroid function abnormalities. In mild iodine 
deficiency (median urinary iodine concentration 50-
99 µg/L6) the consequences observed are less severe, 
the most common being goitre.5
Normally, the thyroid gland will adapt to the low 
amount of iodine available in mild iodine deficiency. 
Iodine auto-regulation will lead to an increase in ac-
tivity of the sodium-iodide-symporter (NIS) as well 
as many other processes, such as H2O2 generation, 
involved in thyroid hormone production.7 Thyroid 
hormone secretion is thereby maintained at sufficient 
levels. However, the thyroid hyperactivity often leads 
to goitre and to the development of multiple thyroid 
nodules with autonomous hormone product. This is 
why hyperthyroidism from multinodular toxic goitre 
is very common in elderly people when iodine intake 
is below the recommended level.
Figure 1 illustrates this latter phenomenon, which 
represents the age-associated incidence of the three 
most common types of hyperthyroidism in the Dan-
ish population before the initiation of a program of 
mandatory salt iodization in Denmark.8 Data were 
collected as part of the DanThyr study, which is the 
monitoring of the Danish iodization program.9 Par-
ticularly to be noted is the steep increase in incidence 
of multinodular toxic goitre with age in this mildly to 
moderately iodine deficient population.
As described in detail in the report on iodine de-
ficiency by WHO/UNICEF/ICCIDD,6 it is important 
that a population have a sufficient iodine intake to 
prevent the consequences of iodine deficiency. On 
the other hand, iodine has complex effects on the 
thyroid gland, as discussed below.
ioDine intake anD autoimmune 
HypotHyRoiDism
The association between iodine intake and thyroid 
disease is U-shaped,10 excessive iodine intake with a 
median urinary iodine concentration above 300 µg/L 
officially labelled as being associated with a higher 
frequency of thyroid autoimmunity.6 Unfortunately, 
the increase in incidence of autoimmune hypothyroid-
ism coming with a higher iodine intake starts already 
at the level of iodine deficiency.5,11
Figure 2 shows the incidence of overt autoim-
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mune hypothyroidism in two Danish regions before 
the Danish iodization program. The two regions had 
different levels of iodine deficiency (moderate and 
mild) caused by a difference in the ground water iodine 
content.12 In Denmark, ground water is universally 
used for drinking, preparation of food, etc. As can 
be seen, the incidence of autoimmune hypothyroid-
ism was nearly 50% higher in the area with only mild 
iodine deficiency compared with moderate iodine 
deficiency.11
Corresponding to this difference in the incidence 
of autoimmune hypothyroidism before iodization of 
salt, a general increase was observed in the incidence of 
hypothyroidism13 and in the prevalence of circulating 
thyroid antibodies14 in the Danish population after 
implementation of a cautious mandatory iodization 
of household salt and salt in bread. The program led 
to an increase in the median urinary iodine concen-
tration in the population from 61 µg/L to 101 µg/L.15
Reports on several other populations have also 
shown that some degree of hypothyroidism is relatively 
rare in mild iodine deficiency and more common when 
iodine intake is adequate or more than adequate.16-19 
Thus, viewed from the narrow standpoint of preventing 
autoimmune hypothyroidism, the population should 
be kept iodine deficient. On the other hand, this is 
associated with a high frequency of other diseases. 
What is the optimal strategy?
Current evidence clearly indicates that iodine de-
ficiency should be avoided6,20 and that this will lower 
the combined burden of disease. Figure 3 illustrates 
the accumulated risks of different degrees of hyper- 
and hypothyroidism in old people who had lived their 
lives with moderate iodine deficiency in the city of 
Randers, Jutland, Denmark and comparable people 
who had lived with recommended iodine intake in 
the city of Skagen, Jutland, Denmark.21 In Skagen 
the ground water iodine content is high,12 caused by 
marine deposits near the aquifer. 22 As illustrated, the 
burden of hyperthyroidism was much lower in Skagen 
with recommended iodine intake, and this more than 
compensated for the higher risk of hypothyroidism.
The rather narrow interval of optimal iodine 
intake with a median urinary iodine concentration 
Figure 1. Age-specific incidence rates (IR) of the three most 
common nosological types of hyperthyroidism in Denmark 
(Graves’ disease, multinodular toxic goitre, and solitary toxic 
adenoma). Data were obtained by prospectively surveying a 
population cohort (person-years of observation: 2,027,208) be-
fore the implementation of the Danish mandatory iodization of 
salt. Reproduced from Carlé A et al8 with permission.
Figure 2. Standardized incidence rates of autoimmune hypo-
thyroidism in Aalborg (AAL) with moderate iodine deficiency 
and in Copenhagen (CPH) with mild iodine deficiency, before 
the implementation of the Danish mandatory iodization of salt. 
The incidence rate was statistically significantly higher in Co-
penhagen than in Aalborg (standardized incidence rate ratio 
1.46 (95% confidence interval 1.23-1.72). Data from Carlé A 
et al.11
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of 100-200 µg/L6 giving the lowest burden of disease 
makes it important to monitor and to control iodine 
intake from diet.23 In a population that is iodine de-
ficient from natural diet, food enriched with iodine 
(typically salt) should be evenly distributed among 
the population. Moreover, intake of food containing 
excessive iodine should be limited.
cessation of toBacco smoking anD tHe 
Risk of autoimmune HypotHyRoiDism
Tobacco smoking is among the leading causes of 
death in most countries. Using data published by the 
United States Centre for Disease Control (CDC), it 
was calculated that in the year 2000 18.1% of deaths 
in the USA were attributable to smoking tobacco.24 
Cessation of smoking reduces the risk of smoking 
associated cardiovascular disease and cancer sub-
stantially, and quitting tobacco has been vigorously 
promoted to prevent disease and death. However, 
as illustrated in Figure 4, cessation of smoking is as-
sociated with a steep, though transient, increase in 
the risk of developing autoimmune hypothyroidism 
within the two first years.25
If autoimmune hypothyroidism were the only 
disease to prevent in the population via cessation of 
smoking, it would not be advisable to encourage smok-
ers to quit; but up to 15 years of lost life expectancy 
caused by smoking26 tips the balance fundamentally. 
Thus, it is not rational to seek to prevent autoimmune 
hypothyroidism by recommending people to continue 
smoking. On the other hand, physicians (and smokers) 
should be aware that nearly any complaint reported 
by someone who has quit smoking within the last two 
years should lead to a test of the thyroid function. In 
Denmark, 85% of the patients who were diagnosed 
with overt autoimmune hypothyroidism within two 
years after quitting smoking would theoretically not 
have developed hypothyroidism during this period 
of time if they had continued to smoke.25
The mechanism behind the surge of autoimmune 
hypothyroidism after cessation of smoking is currently 
unknown. Several studies have shown a lower preva-
lence of thyroid antibodies in smokers compared with 
non-smokers,27-29 while it is also reported that people 
who quit smoking may become positive for thyroid 
Figure 3. Comparative epidemiological study of hyper- and 
hypothyroidism among 75-80 year-old Danish residents of 
Randers (n=212) and Skagen (n=218). Median urinary iodine 
concentration was 55 µg/L in Randers and 160 µg/L in Skagen. 
Participants from Randers often (26%) had visible goitre by 
clinical examination. In Skagen none had goitre. Some degree 
of hyperthyroidism or previous therapy for hyperthyroidism 
was significantly more common in Randers (p<0.001), whereas 
hypothyroidism was more common in old residents in Skagen 
(p=0.019). Having no history or biochemical evidence of thy-
roid dysfunction it was more common in Skagen (p=0.002). 
Reproduced from Andersen S et al22 with permission.
Figure 4. Risk of developing hypothyroidism according to 
smoking history. Odds ratios (with 95% confidence intervals) 
for the different groups are presented and connected with lines 
to illustrate a hypothetical process from non-smoker to current 
and then to ex-smoker with different time intervals since quit-
ting smoking. Each group was compared with never-smokers in 
a multivariate logistic model including also alcohol consump-
tion and family history of hypothyroidism. Reproduced from 
Carlé A et al25 with permission.
34 P. LauRBERG Et aL
antibodies.30 Smokers have a lower prevalence of 
subclinical hypothyroidism than non-smokers31 but, 
as illustrated in Figure 4, we found no significant 
protective effect of current smoking on the incidence 
of overt autoimmune hypothyroidism, even though 
the odds ratio was slightly below one. This lack of 
protection from current smoking is in accordance with 
results of a previous meta-analysis of the association 
between smoking and overt hypothyroidism.32
After two years had passed since quitting, the odds 
ratio returned to below one (Figure 4), but this was 
not statistically significant. Our study did not have 
the power to evaluate whether the long-term result 
of quitting smoking is a lower risk of autoimmune 
hypothyroidism. If all the participants who had quit 
smoking at some point of time were combined into 
one group, the risk would not be different from never-
smokers,25 and it may be speculated that those who 
developed overt autoimmune hypothyroidism shortly 
after quitting smoking would have developed the 
disease later if they had continued smoking.
The conclusion that can be drawn from the results 
illustrated in Figure 4 is that optimal behaviour is never 
to start smoking. People would then not be exposed 
to the inconvenience and risks of quitting smoking. 
Autoimmune hypothyroidism is not the only disease 
that may develop in people who quit smoking. Body 
weight often increases after quitting33 and there is an 
increase in risk of developing diabetes.34,35
It is interesting to speculate on some possible 
mechanisms behind the rebound in autoimmunity 
leading to hypothyroidism in the first years after 
quitting smoking.
One possibility is that the increase in risk is caused 
by the thyroid follicular cells being exposed to extra 
iodide after cessation of smoking. Smokers have a high 
generation of thiocyanate from cyanide in tobacco 
smoke, and thiocyanate is a competitive inhibitor of 
NIS transport of iodide.36 As judged from the inhibi-
tory effect of smoking on iodide transport into milk 
of breast feeding mothers (no iodine autoregulation 
of NIS occurs in the mammary gland and inhibition 
of NIS leads to a decrease in milk iodine content), 
smoking primarily reduces iodide transport by NIS 
into the thyroid by around 50%.37 In the thyroid, 
such inhibition of NIS will be autoregulated by en-
hancement of NIS gene transcription.7 It may be 
speculated that after many years of smoking, chroni-
cally up-regulated thyroidal NIS may stay high for a 
period after cessation of smoking. The excess iodide 
transported into the thyroid may increase the risk of 
autoimmune hypothyroidism, similar to the increase 
in risk of hypothyroidism seen after excess iodine 
intake with diet.5
Another possible mechanism behind the develop-
ment of autoimmune hypothyroidism after cessation 
of smoking is oxidative damage caused by sudden 
exposure to oxygen in tissues. Smokers tend to have 
a partial oxygen deficiency in tissues,38 and it may 
be speculated that the sudden increase in tissue 
oxygen after cessation of smoking could promote 
autoimmunity via reactive oxygen species mediated 
tissue damage. This would likely act in concert with 
the effect of increasing iodide content in the thyroid.
A third possibility is that nicotine or other com-
pounds in smoke dampen thyroid autoimmune activity 
by unknown mechanisms, somewhat similar to the 
protective effect of alcohol consumption discussed 
below. This hypothesis may be supported by the 
finding of a lower prevalence of circulating thyroid 
antibodies in smokers27-29 and also by a recent report 
in an animal model of autoimmunity indicating that 
a nicotine derivative may protect against thyroid 
autoimmunity.39 By contrast, current smoking did 
not protect against overt autoimmune hypothyroid-
ism in our study (Figure 4), which may argue against 
this hypothesis.
alcoHol consumption anD autoimmune 
HypotHyRoiDism
In the report on causes of death in the USA in 
the year 2000, 3.5% of deaths were associated with 
excess intake of alcohol.24 On the other hand, it is 
known from series of studies that a moderate con-
sumption of alcohol (compared with total abstention 
from alcohol) is associated with reduced risk of many 
diseases.40-46 Autoimmune hypothyroidism is one of 
the diseases that are less common in people having 
moderate alcohol consumption.
Figure 5 illustrates the odds ratio (OR) for develop-
ing autoimmune hypothyroidism in people split into 
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groups according to habits of alcohol intake.47 The 
reference group in this analysis was people consuming 
1-10 units of alcohol per week. One unit corresponds 
to a glass of wine or beer or spirit (~10-12 g of alco-
hol) and 1-10 units per week was the most common 
level of consumption in the Danish population under 
study. As shown in the figure, the OR for developing 
hypothyroidism was twice as high in alcohol abstain-
ers and around half in people with the higher alcohol 
intake of 11-20 units/week. The small group (~6% 
of participants) reporting a higher than this level 
of alcohol consumption was not different from the 
reference. In a separate analysis, no difference in 
protective effect was observed between people who 
predominantly consumed beer vs. wine consumers.47
Thus, moderate alcohol intake was associated with 
a dose-dependent protection against development of 
autoimmune hypothyroidism. The mechanism lead-
ing to this less aggressive reaction of the immune 
system against the thyroid gland when exposed to 
alcohol is unknown. In a recent Dutch follow-up 
study of relatives to patients with autoimmune thyroid 
disease, a similar protective effect of alcohol on the 
development of autoimmune hypothyroidism was 
observed.48 Among 38 cases of overt hypothyroidism 
6.7% consumed >10 units of alcohol/week, whereas 
this was 23.7% of the 76 matched controls that had 
not developed hypothyroidism.
We previously observed a dose-dependent pro-
tective effect of alcohol intake on development of 
goitre and solitary thyroid nodules,49 and alcohol 
abusers tend to have a small fibrotic thyroid.50 It 
is possible that there is some overlap between the 
mechanisms leading to a lower rate of growth and 
nodule formation and those giving a lower tendency 
to autoimmune destruction of the thyroid gland. On 
the other hand, a protective effect of alcohol intake 
has also been described for some other autoimmune 
diseases,51-53 which may suggest a more direct effect 
of alcohol on the immune system. There is a complex 
interaction between alcohol and various components 
of the immune system, and alcohol has been shown 
to dampen some immune responses both in animals 
and in humans.54-56
an example of HigH vs. low Risk  
of autoimmune HypotHyRoiDism  
anD tHe possiBility of pRevention
The incidence of autoimmune hypothyroidism in-
creases by around 50% per advancing decade of life,11 
it is 3.5 times higher in women than in men,11 and it 
seems to be three times as high in white Caucasians 
as in people of black African ancestry.57 Age, sex, 
and race are non-modifiable risk factors, but iodine 
intake, smoking, and alcohol intake are modifiable.
As illustrated in the present report, people with suf-
ficient iodine intake according to the WHO/UNICEF/
ICCIDD recommendations6 have a 1.5-2 times higher 
risk of developing autoimmune hypothyroidism com-
pared with people having mild to moderate iodine 
deficiency, and people abstaining from alcohol have 
a four times higher risk than people who consume 
11-20 units of alcohol per week. Moreover, people 
who stop smoking have for a two-year period a six 
times higher risk than those who continue smoking.
Our analyses give no indication that the differ-
ences in risk associated with these three factors are 
interdependent. The following comparison illustrates 
how strongly modifiable the risk of autoimmune hy-
Figure 5. The dose-effect of alcohol consumption on the oc-
currence of overt autoimmune hypothyroidism. Data from 140 
cases and 560 individually matched controls from the same 
population and undergoing identical investigational programs 
were analysed in a conditional multivariate regression model. 
Odds ratios (with 95% confidence limits) for developing hy-
pothyroidism were calculated in groups having different levels 
of alcohol consumption. Reference in all comparisons was the 
group having a consumption of 1-10 units per week. Repro-
duced from Carlé A et al47 with permission.
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pothyroidism is by a change of environment:
The risk of developing autoimmune hypothyroid-
ism during the year to come in a person who quit 
smoking, who does not consume alcohol, and who 
has an average recommended iodine intake of 150-
200 µg/day is in the order of 30 times higher than it 
would have been if the same person had continued 
smoking, had regularly consumed two units of alcohol 
per day, and had been iodine deficient with a daily 
intake of 50-100 µg iodine.
As discussed, although prevention of autoimmune 
hypothyroidism via such a change in environment is 
incompatible with current public health programs, the 
example illustrates the profound effect of modifiable 
environment on the risk of developing autoimmune 
hypothyroidism. In this disorder, considered by many 
to be mostly dependent on non-modifiable genetic 
aberration, simple changes of environment are ca-
pable of modifying the risk of disease development 
by a factor of 30.
conclusion
The risk of autoimmune hypothyroidism is, ac-
cording to strong evidence, profoundly modifiable 
by a change of environment. However, modification 
of environment to reduce the risk of hypothyroidism 
may unacceptably increase the risk of other diseases. 
Thus, prevention of autoimmune hypothyroidism is 
somewhat similar to the problem facing prehistoric 
Greek sailors endeavouring to pass between Scylla 
and Charybdis: manoeuvring the ship to avoid one 
monster would bring them within reach of the other 
monster. Nonetheless, some reasonable suggestions 
can be put forward.
Based on the reduction in risk of developing au-
toimmune hypothyroidism and some other diseases, 
people who prefer to have daily moderate alcohol 
consumption can be reassured.
The fight against smoking should focus even more 
on convincing people never to start regular smoking 
in the first place. Smokers who quit should have their 
thyroid function tested if they present any symptoms 
or signs compatible with thyroid dysfunction.
Iodine intake of an iodine deficient population 
should be brought to the level where iodine deficiency 
disorders are prevented, but not higher. Iodine intake 
of populations should be monitored as part of public 
health programs.
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